The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs
Abstract
Summary: Pharmacoresistance to antiepileptic drugs (AEDs) is a barrier to seizure freedom for many persons with epilepsy. For nearly two decades, pharmacoresistance has been framed in terms of factors affecting the access ofAEDs to their molecular targets in the brain or the actions of the drugs on these targets. Shortcomings in this prevailing view led to the formulation of the intrinsic severity hypothesis of pharmacoresistance toAEDs, which is based on the recognition that there are neurobiologic factors that confer phenotypic variation among individuals with etiologically similar forms of epilepsy and postulates that more severe epilepsy is more difficult to treat withAEDs. In recent years, progress has been made identifying potential genetic mechanisms of variation in epilepsy severity, including subclinical mutations in ion channels that increase or reduce epilepsy severity in mice. Efforts are underway to identify clinically important genetic modifiers. If it can be demonstrated that such severity factors play a role in pharmacoresistance, treatments could be devised to reverse severity mechanisms. By overcoming pharmacoresistance, this new approach to epilepsy therapy may allow drug refractory patients to achieve seizure freedom without side effects.Keywords
This publication has 79 references indexed in Scilit:
- Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibilityProceedings of the National Academy of Sciences, 2011
- Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plusNeurobiology of Disease, 2011
- Altered Function of the SCN1A Voltage-gated Sodium Channel Leads to γ-Aminobutyric Acid-ergic (GABAergic) Interneuron AbnormalitiesJournal of Biological Chemistry, 2010
- Identification of Pharmacoresistant EpilepsyNeurologic Clinics, 2009
- Neurosteroid Replacement Therapy for Catamenial EpilepsyNeurotherapeutics, 2009
- Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsyBrain, 2008
- Antiepileptic Drug Transport—Of Mice and MenEpilepsy Currents, 2008
- Likelihood of seizure remission in an adult population with refractory epilepsyAnnals of Neurology, 2007
- Molecular Targets for Antiepileptic Drug DevelopmentNeurotherapeutics, 2007
- Refractory Epilepsy: One Size Does Not Fit AllEpilepsy Currents, 2006